Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MediPharm Labs responds to allegations from dissident shareholder Apollo, intentionally or recklessly fabricated as part of its campaign of misinformation.
-
VANCOUVER, British Columbia, May 29, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol...
-
MariMed launches MycroDose by Nature's Heritage, combining THC with functional mushrooms in a pill form
-
Dublin, May 29, 2025 (GLOBE NEWSWIRE) -- The "Domain Names - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Domain Names was sized at...
-
Letter to Shareholders from MediPharm Board of Directors, May 28, 2025
-
Achieved net revenue of $12.4 million, representing a 39.2% increase compared to the same quarter in prior yearGenerated Adjusted EBITDA1 of $0.7 million, an improvement of $1.1 million...
-
MediPharm Labs Cautions Shareholders about Dissident Nominees’ Governance Failures at Check-Cap Ltd.
TORONTO, May 23, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (“MediPharm”, the “Company”, or “we”), a pharmaceutical company specialized in precision-based cannabinoids, today provided...
-
VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today reported the Company’s consolidated interim financial...
-
VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and...
-
TORONTO, May 21, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today alerted its...